News
ADILW
0.0009
0.00%
0.00
BUZZ-U.S. STOCKS ON THE MOVE-Super Micro Computer, Decker Outdoor, DoorDash
U.S. Stock index futures were muted on Monday after the S&P 500 and Nasdaq's record-closing highs in the prior session. Dow e-minis were down 0.26% at 39,041.25. Super Micro Computer, Decker Outdoor, DoorDash were among the day's top stocks.
Reuters · 03/04 12:34
BUZZ-U.S. STOCKS ON THE MOVE-Madrigal Pharma, Copper miners, NetApp
S&P 500 and Nasdaq climb on Friday as chipmakers extend gains. Dow Jones Industrial Average up 0.17% at 39,060.77. Copper miners, NetApp and Madrigal Pharma are among the day's losers. Treasury yields dip on soft economic data and remarks from Fed officials.
Reuters · 03/01 19:20
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Adial Pharmaceuticals, Inc. Is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders. The Company has entered into a definitive agreement for the immediate exercise of certain outstanding warrants. The gross proceeds from the exercise of the warrants are expected to be $3,530,500.
Barchart · 03/01 18:00
BUZZ-U.S. STOCKS ON THE MOVE-Cooper, US energy stocks, Vista Outdoor
U.S. Stocks struggled for direction on Friday. Dow Jones Industrial Average was down 0.01% at 38,992.07. The top three S&P 500 percentage gainers were NetApp, Dell and The Cooper Companies. The Nasdaq Composite was up 0.33%.
Reuters · 03/01 15:52
BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Chemours, C3.ai
Wall Street's main indexes rose on Thursday. Key inflation metric came in line with estimates, raising hopes of interest rate cuts by the U.S. Fed. Dow Jones Industrial Average was flat, the S&P 500 was up 0.29%. Hormel Foods and C3.ai were among the top percentage gainers. Boeing Co was down 1.6%.
Reuters · 02/29 15:59
BUZZ-U.S. STOCKS ON THE MOVE-Shift4 Payments, Chart Industries, Applied Therapeutics
Wall Street's main indexes slipped on Wednesday. Dow Jones Industrial Average was down 0.10% at 38,933.98. Top three S&P 500 percentage gainers: Axon Enterprise, eBay. The top three Nasdaq percentage losers: Chart Industries, Applied Therapeutics.
Reuters · 02/28 19:26
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Patent number 11,905,562 was issued on February 20, 2024 by the United States Patent and Trademark Office. The patent covers the Company's lead investigational new drug product, AD04. Adial Pharmaceuticals is focused on developing therapies for the treatment and prevention of addiction and related disorders.
Barchart · 02/28 08:30
BRIEF-Adial Pharmaceuticals Receives Final Reimbursement Payment From Adovate
Reuters · 12/20/2023 14:06
Adial Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Reuters · 08/21/2023 21:01
Adial Pharmaceuticals Inc expected to post a loss of $1.50 a share - Earnings Preview
Reuters · 08/18/2023 20:03
Adial Pharmaceuticals: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Press release · 07/27/2023 21:03
Adial Pharmaceuticals: [Amend]General form for registration of securities under the Securities Act of 1933
Press release · 07/13/2023 21:03
Adial Pharmaceuticals: Current report
Press release · 07/10/2023 22:01
Adial Pharmaceuticals: General form for registration of securities under the Securities Act of 1933
Press release · 06/23/2023 13:01
BRIEF-Adial Pharmaceuticals Inc Files With SEC For Resale Of Up To 10.2 Mln Common Shares By Alumni Capital LP
Reuters · 06/23/2023 10:11
Adial Pharmaceuticals: Current report
Press release · 06/09/2023 17:06
Adial Pharmaceuticals: Current report
Press release · 06/02/2023 14:03
Adial Pharmaceuticals: Statement of changes in beneficial ownership of securities
Press release · 06/02/2023 14:03
Adial Pharmaceuticals: Statement of changes in beneficial ownership of securities
Press release · 05/25/2023 21:04
More
Webull provides a variety of real-time ADILW stock news. You can receive the latest news about Adial Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About ADILW
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. The Company’s drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is used for the treatment of AUD in subjects with certain target genotypes, which were identified using its companion diagnostic genetic test. AD04 is a genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for the treatment of AUD. The Company’s AD04 also has the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.